Korean J Hepatol.
2010 Dec;16(4):353-354. 10.3350/kjhep.2010.16.4.353.
Which treatment modality should we choose for advanced hepatocellular carcinoma?
- Affiliations
-
- 1Department of Internal Medicine, Yonsei Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Korea. dyk1025@yuhs.ac
- KMID: 1117690
- DOI: http://doi.org/10.3350/kjhep.2010.16.4.353
Abstract
- No abstract available.
Keyword
MeSH Terms
-
Adult
Aged
Antineoplastic Agents/administration & dosage
Antineoplastic Combined Chemotherapy Protocols
Benzenesulfonates/administration & dosage
Carcinoma, Hepatocellular/mortality/*therapy
Chemoembolization, Therapeutic
Cisplatin/administration & dosage
Fluorouracil/administration & dosage
Humans
Infusions, Intra-Arterial
Liver Neoplasms/mortality/*therapy
Middle Aged
Pyridines/administration & dosage
Survival Rate
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Emerging Trends in the Treatment of Advanced Hepatocellular Carcinoma: A Radiological Perspective
- Newer treatments for advanced hepatocellular carcinoma
- Successful Treatment of Stereotactic Body Radiation Therapy Combined with Transarterial Chemolipiodolization for Hepatocellular Carcinoma with Biliary Obstruction
- Imaging Diagnosis of Hepatocellular Carcinoma
- Treatments Other than Sorafenib for Patients with Advanced Hepatocellular Carcinoma
